Altre lingue Protalix BioTherapeutics, Inc.

Azioni

PLX

US74365A3095

Mercato chiuso - Nyse Altri mercati azionari 22:00:00 29/04/2024			Variaz. 5gg	Var. 1 gen.
1,2 ^USD	+4,35%		+1,69%	-32,58%

14/03	Transcript : Protalix BioTherapeutics, Inc., 2023 Earnings Call, Mar 14, 2024
14/03	Protalix BioTherapeutics, Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results	15/03
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024	08/03
Protalix BioTherapeutics to Participate in the 2024 BIO CEO and Investor Conference	26/02
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results	07/11
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11
Protalix: Q3 Earnings Snapshot	06/11
Earnings Flash (PBDA) PROTALIX BIOTHERAPEUTICS Reports Q3 Revenue $10.3M	06/11
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023	31/10/23
Protalix BioTherapeutics : PLX Corporate Presentation (October 2023)	23/10/23
Protalix BioTherapeutics Issues Statement Regarding Security Situation in Israel	10/10/23
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors	13/09/23
Protalix Biotherapeutics Appoints Eliot Richard Forster to Succeed Zeev Bronfeld as Chairman, Effective as of September 14, 2023	12/09/23
Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference	07/09/23
Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results	08/08/23
Protalix BioTherapeutics : PLX Corporate Presentation (August 2023)	07/08/23
Earnings Flash (PBDA) PROTALIX BIOTHERAPEUTICS Reports Q2 Revenue $35.1M	07/08/23
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	07/08/23
Protalix BioTherapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference	02/08/23
Protalix BioTherapeutics to Announce Second Quarter 2023 Financial and Business Results on August 7, 2023	01/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Protalix BioTherapeutics, Inc.

Azioni

PLX

US74365A3095

Altre lingue

Filtri